Adalimumab Dose Reduction and Withdrawal in Stable Non-Infectious Pediatric Uveitis: An Open-Label, Prospective, Pilot Study-Reference-Cited by-同舟云学术

Adalimumab Dose Reduction and Withdrawal in Stable Non-Infectious Pediatric Uveitis: An Open-Label, Prospective, Pilot Study

Published:2024-04-23 Issue: Volume: Page:1-8
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Yuan P. D.¹²,Hu Y. W.¹³,Chen X. Q.¹,Chen G. Y.¹,Pan Y.¹,Lao H. Y.¹,Liang D.¹^ORCID

Affiliation:

1. State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-sen University, Guangzhou, China

2. Department of Ophthalmology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China

3. Department of Ophthalmology, The Second Affiliated Hospital, Nanchang University, Nanchang, China

Funder

State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China

Science and Technology Planning Projects of Guangdong Province

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2024.2343084

Reference30 articles.

1. The Eyes Have it

2. Visual loss associated with pediatric uveitis in english primary and referral centers

3. Special considerations in the evaluation and management of uveitis in children

4. Adalimumab in Patients with Active Noninfectious Uveitis

5. Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comment on “Adalimumab Dose Reduction and Withdrawal in Stable Non-Infectious Pediatric Uveitis: An Open- Label, Prospective, Pilot Study”;Ocular Immunology and Inflammation;2024-08-15